Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > The GMP Letter > Failure to Implement CAPA Cited In BioMerieux Warning Letter

The GMP Letter

October 2012

Failure to Implement CAPA Cited In BioMerieux Warning Letter

The FDA has warned BioMerieux for several violations related to rework procedures and corrective and preventive actions (CAPA) for its microbial detection systems.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Analyst: New Hospira Warning Raises Questions on Quality Culture Report Points to Steep Four-Year Rise in Device Warning Letters CDRH Official: Compliance Approach May Need Tweaks, More Flexibility Warning: Inspection Response Lacks ‘Holistic’ Action Plan for Defects

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.